TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
TFA Therapeutics's EPS for the twelve months ending Dec 31, 2023 was $0.01. For fiscal 2025 it was $0.00. The highest annual figure on record is $0.01 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.00 | – |
| FY2024 | Dec 31, 2024 | $0.00 | -100.0% |
| FY2023 | Dec 31, 2023 | $0.01 | – |
| FY2022 | Dec 31, 2022 | -$0.01 | – |
| FY2021 | Dec 31, 2021 | -$4.91 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0.01 | – |
| Q4 FY2022 | Dec 31, 2022 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?